Cited 0 time in
DPP4 inhibitor plus SGLT2 inhibitor as combination therapy to metformin in patients with type 2 diabetes
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 박정환 | - |
| dc.date.accessioned | 2024-12-05T19:30:30Z | - |
| dc.date.available | 2024-12-05T19:30:30Z | - |
| dc.date.issued | 2023-05-12 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/201305 | - |
| dc.title | DPP4 inhibitor plus SGLT2 inhibitor as combination therapy to metformin in patients with type 2 diabetes | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 제36차 대한당뇨병학회 춘계학술대회 | - |
| dc.citation.conferencePlace | 광주김대중컨벤션센터 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
